Skip to content 
AMM 226: BOTOX Approval in China Redefines Jawline Aesthetics
October 08, 2024
This episode discusses the recent approval of BOTOX® Cosmetic by Allergan Aesthetics in China for treating masseter muscle prominence (MMP), marking it as the first neurotoxin approved for this use in the country. Professor Sun Jiaming from Union Hospital shares insights into the rising demand for minimally invasive facial contouring among Asians. Clinical trials reveal a significant reduction in facial width and improvements in social interaction, attractiveness, and confidence for those receiving the treatment. Learn about the potential global impact and what this development means for individuals seeking a more refined jawline.
Quick Takes
- Allergan Aesthetics announces BOTOX® Cosmetic approval in China for treating masseter muscle prominence (MMP)
- Growing demand for minimally invasive facial contouring options among Asians highlighted by Professor Sun Jiaming
- Clinical trials show significant reduction in facial width with BOTOX® treatment, enhancing social interaction, attractiveness, and confidence
Episode Transcript
Today is October 8th, 2024. Allergan Aesthetics, part of AbbVie, has announced that BOTOX® Cosmetic has become the first neurotoxin approved in China for treating masseter muscle prominence (MMP). This muscle, involved in chewing, can contribute to a wider, more square lower face shape, which many seek to slim down.
Professor Sun Jiaming, Director of Plastic Surgery at Union Hospital, highlights the growing demand for minimally invasive options for facial contouring among Asians. The significant reduction in facial width observed in clinical trials, around 5.2mm more than with placebo, emphasizes the effectiveness of BOTOX® treatment. Subjects experienced enhancements in social interaction, attractiveness, and confidence.
This approval in China marks a major milestone, offering a new solution for those desiring a refined jawline. With plans for global expansion, Allergan Aesthetics is poised to address this aesthetic concern worldwide .
